IAP antagonists induce anti-tumor immunity in multiple myeloma
Nature Medicine2016Vol. 22(12), pp. 1411–1420
Citations Over TimeTop 10% of 2016 papers
Marta Chesi, Noweeda Mirza, Victoria M. Garbitt, Meaghen E. Sharik, Amylou C. Dueck, Yan W. Asmann, Ilseyar Akhmetzyanova, Heidi Kosiorek, Arianna Calcinotto, Daniel L. Riggs, Niamh Keane, Gregory Ahmann, Kevin M. Morrison, Rafaël Fonseca, Martha Q. Lacy, David Dingli, Shaji Kumar, Sikander Ailawadhi, Angela Dispenzieri, Francis K. Buadi, Morie A. Gertz, Craig B. Reeder, Yi Lin, Asher Chanan‐Khan, A. Keith Stewart, David Fooksman, P. Leif Bergsagel
Related Papers
- → Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)(2017)70 cited
- → Disturbed XIAP and XAF1 Expression Balance Is an Independent Prognostic Factor in Gastric Adenocarcinomas(2008)31 cited
- Research Progress of the Inhibitor-of-protein XIAP(2003)
- → Inhibitor of apoptosis protein XIAP and malignant tumor(2010)
- → Faculty Opinions recommendation of Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP).(2017)